Skip to main content
. 2013 Jul 18;4(6):502–513. doi: 10.7150/jca.6503

Table 5.

Univariate and multivariate analysis of factors contributing to overall survival (OS) and recurrence-free survival (RFS) after surgical resection in patients without liver cirrhosis (n=213).

OS Multivariate analysis (OS) RFS Multivariate analysis (RFS)
Variables n P-valuea HR 95%CI P-valueb P-valuea HR 95%CI P-valueb
Age ≥70 years (yes/no) 106/107 0.527 0.939
Gender (male/female) 170/43 0.548 0.091 0.650 0.397-1.065 0.087
Cause of liver disease
Hepatitis B/hepatitis C/nonB nonC 27/103/83 0.963 0.733
HCC stage (I, II/III, IV) 139/74 0.001 0.360 0.116-1.118 0.077 <0.001 0.560 0.263-1.194 0.133
Maximum tumor size ≥4 cm (yes/no) 125/88 0.001 0.477 0.264-0.864 0.015 0.002 0.643 0.413-1.000 0.050
Tumor number (single/multiple) 146/67 0.008 1.616 0.522-5.006 0.405 <0.001 0.979 0.462-2.074 0.955
Total bilirubin ≥0.8 mg/dl (yes/no) 77/136 0.604 0.578
Serum albumin ≥3.9 g/dl (yes/no) 155/58 0.112 0.161
AST ≥50 IU/l (yes/no) 105/108 0.552 0.096 1.373 0.850-2.216 0.195
ALT ≥50 IU/l (yes/no) 94/119 0.132 0.060 0.940 0.562-1.572 0.813
ALP ≥300 IU/l (yes/no) 79/134 0.644 0.002 0.718 0.489-1.053 0.090
GGT ≥80 IU/l (yes/no) 99/114 0.038 0.651 0.403-1.053 0.080 <0.001 0.642 0.435-0.949 0.026
Platelets ≥13×104/mm3 (yes/no) 178/35 0.543 0.558
Prothrombin time ≥88 % (yes/no) 154/59 0.444 0.115
Diabetes mellitus (yes/no) 69/143 0.903 0.382
Body mass index ≥23 kg/m2 (yes/no) 96/117 0.981 0.210
AFP ≥20 ng/ml (yes/no) 82/131 0.028 0.694 0.424-1.135 0.146 0.044 0.753 0.514-1.103 0.146
DCP ≥200 mAU/ml (yes/no) 124/89 0.011 0.977 0.518-1.842 0.943 0.010 1.159 0.723-1.859 0.539
Microscopic vascular invasion (yes/no) 74/139 0.015 0.814 0.469-1.413 0.464 0.004 0.740 0.489-1.122 0.156
Microscopic surgical margin (yes/no) 52/161 0.547 0.129

HR; hazard ratio, CI; confidence interval, HCC; hepatocellular carcinoma, AST; aspartate aminotransferase, ALT; alanine aminotransferase, ALP; alkaline phosphatase, GGT; gamma glutamyl transpeptidase, AFP; alpha-fetoprotein, DCP; des-γ-carboxy prothrombin, a; Log-rank test, b; Cox proportional hazard model.